Bagsværd, Denmark, 3 February 2026 – Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for 2025 and released the 2026 full-year sales and operating profit ...
CEO Robert Mauch announced the completion of the acquisition of the majority of the remaining equity interest in OneOncology, emphasizing, "we are raising our fiscal 2026 guidance to reflect year-over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results